Chuck Papageorgiou

Institute Fellow

NeuroEM

LinkedInEmailWebsite

Chuck Papageorgiou is Chief Executive Officer of NeuroEM Therapeutics, a clinical stage biotechnology company developing technologies designed to support brain health and address cognitive decline associated with aging and neurodegenerative disease.

A seasoned executive, entrepreneur, and enterprise technologist, Chuck brings more than two decades of experience leading business transformation, organizational turnarounds, mergers and acquisitions, technology strategy, and startup growth. He has led organizations ranging from early stage companies to global operations with more than 10,000 employees and has advised on major restructuring and M&A transactions across multiple industries.

Chuck is also Managing Partner of Ideasphere Labs, an advisory and consulting firm that provides hands on leadership and execution support in strategy, operations, technology, turnarounds, outsourcing, corporate alliances, and mergers and acquisitions. His clients have included private equity firms, venture capital organizations, and corporations around the world.

As an entrepreneur, Chuck has founded and helped launch multiple companies and has extensive experience translating complex ideas into practical strategies, operating models, and execution plans. His leadership style combines strategic vision with an operator mindset and a strong focus on results, accountability, and building high performing teams.

Chuck has also been actively involved in Florida's entrepreneurship ecosystem through board, advisory, and entrepreneur in residence roles supporting emerging companies, founders, and innovation initiatives.

Outside of work, Chuck enjoys spending time with his family, woodworking, and saltwater fishing.

Stay Ahead of Digital and Business Transformation.

Practical insights, research, and field-tested perspectives from the Institute. Unsubscribe anytime.